Nucleic Acids Research, 1994, Vol. 22, No. 15 3005-3010
© 1994
MOLECULAR BIOLOGY |
Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage
Laboratory of Molecular Genetics, National Institute on Aging NIH, 4940 Eastern Avenue, Baltimore, MD 21224, USA
*To whom correspondence should be addressed
Received May 13, 1994. Revised June 20, 1994. Accepted June 20, 1994.
The human excision repair gene ERCC-1 gene restores normal resistance to UV and mitomycin C in excision repair deficient Chinese hamster ovary cells of complementation group 1. To investigate the involvement of the ERCC-1 gene in gene-specific repair of bulky lesions, we have studied the removal of damage induced by the antitumor agent cisplatin in CHO mutant 43-3B cells of group 1, with or without transfection with the ERCC-1 gene. Firstly, we determined the contribution of the ERCC-1 gene to the repair of interstrand crosslinks (ICL) induced by cisplatin and found efficient removal of ICLs from the dihydrofolate reductase (DHFR) gene in the ERCC-1 transfected 43-3B cells. We then assessed the contribution of ERCC-1 to the repair of intrastrand adducts (IA) induced by cisplatin. Compared to the wild-type parental cell line, the ERCC-1 transfected 43-3B cells repaired the lAs in the DHFR gene inefficiently. Thus, our data suggest that the ERCC-1 gene is more involved in the repair of interstrand crosslinks than in the removal of intrastrand adducts.
+Present address: Laboratoire de Pharmacologie et de Toxicologie Fondamentales, 205 Route de Narbonne, 31077 Toulouse Cedex, France
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Langer, K. Specht, K. Becker, P. Ewald, M. Bekesch, M. Sarbia, R. Busch, M. Feith, H. J. Stein, J.-R. Siewert, et al. Association of Pretherapeutic Expression of Chemotherapy-Related Genes with Response to Neoadjuvant Chemotherapy in Barrett Carcinoma Clin. Cancer Res., October 15, 2005; 11(20): 7462 - 7469. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Papouli, M. Defais, and F. Larminat Overexpression of Metallothionein-II Sensitizes Rodent Cells to Apoptosis Induced by DNA Cross-linking Agent through Inhibition of NF-kappa B Activation J. Biol. Chem., February 8, 2002; 277(7): 4764 - 4769. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. G. Dronkert, J. de Wit, M. Boeve, M. L. Vasconcelos, H. van Steeg, T. L. R. Tan, J. H. J. Hoeijmakers, and R. Kanaar Disruption of Mouse SNM1 Causes Increased Sensitivity to the DNA Interstrand Cross-Linking Agent Mitomycin C Mol. Cell. Biol., July 1, 2000; 20(13): 4553 - 4561. [Abstract] [Full Text] |
||||
![]() |
W. H. Hanneman, M. E. Legare, S. Sweeney, and J. C. Schimenti Cisplatin increases meiotic crossing-over in mice PNAS, August 5, 1997; 94(16): 8681 - 8685. [Abstract] [Full Text] [PDF] |
||||



